nodes	percent_of_prediction	percent_of_DWPC	metapath
Vitamin E—HMOX1—artery—Kawasaki disease	0.037	0.0591	CbGeAlD
Vitamin E—HMOX1—endothelium—Kawasaki disease	0.0313	0.0499	CbGeAlD
Vitamin E—HMOX1—Overview of nanoparticle effects—CRP—Kawasaki disease	0.0239	0.0639	CbGpPWpGaD
Vitamin E—PRKCA—artery—Kawasaki disease	0.0237	0.0379	CbGeAlD
Vitamin E—PRKCB—heart—Kawasaki disease	0.0226	0.0362	CbGeAlD
Vitamin E—PRKCA—endothelium—Kawasaki disease	0.02	0.032	CbGeAlD
Vitamin E—HMOX1—myocardium—Kawasaki disease	0.0195	0.0312	CbGeAlD
Vitamin E—PPP2CA—PLK1 signaling events—CENPU—Kawasaki disease	0.0194	0.0517	CbGpPWpGaD
Vitamin E—DGKA—heart—Kawasaki disease	0.0187	0.0299	CbGeAlD
Vitamin E—PPP2CA—heart—Kawasaki disease	0.0185	0.0295	CbGeAlD
Vitamin E—DGKA—skin of body—Kawasaki disease	0.0183	0.0293	CbGeAlD
Vitamin E—PPP2CA—skin of body—Kawasaki disease	0.0181	0.0289	CbGeAlD
Vitamin E—GCLC—cardiac ventricle—Kawasaki disease	0.018	0.0287	CbGeAlD
Vitamin E—GCLC—myocardium—Kawasaki disease	0.0169	0.027	CbGeAlD
Vitamin E—GSTA2—gall bladder—Kawasaki disease	0.0166	0.0266	CbGeAlD
Vitamin E—GSTM3—cardiac ventricle—Kawasaki disease	0.016	0.0256	CbGeAlD
Vitamin E—GSTM3—neck—Kawasaki disease	0.0159	0.0254	CbGeAlD
Vitamin E—PPP2CB—heart—Kawasaki disease	0.0157	0.0251	CbGeAlD
Vitamin E—GSTM3—myocardium—Kawasaki disease	0.0151	0.0241	CbGeAlD
Vitamin E—GSTO1—cardiac ventricle—Kawasaki disease	0.0149	0.0238	CbGeAlD
Vitamin E—GSTO1—neck—Kawasaki disease	0.0148	0.0237	CbGeAlD
Vitamin E—GSTO1—myocardium—Kawasaki disease	0.014	0.0224	CbGeAlD
Vitamin E—SOD1—cardiac ventricle—Kawasaki disease	0.0137	0.0219	CbGeAlD
Vitamin E—HMOX1—heart—Kawasaki disease	0.0136	0.0218	CbGeAlD
Vitamin E—HMOX1—skin of body—Kawasaki disease	0.0133	0.0213	CbGeAlD
Vitamin E—PRKCA—neck—Kawasaki disease	0.0132	0.0211	CbGeAlD
Vitamin E—SOD1—myocardium—Kawasaki disease	0.0129	0.0206	CbGeAlD
Vitamin E—PRKCA—myocardium—Kawasaki disease	0.0125	0.02	CbGeAlD
Vitamin E—NQO1—gall bladder—Kawasaki disease	0.012	0.0191	CbGeAlD
Vitamin E—GCLC—heart—Kawasaki disease	0.0118	0.0188	CbGeAlD
Vitamin E—PPP2CB—Resolution of Sister Chromatid Cohesion—CENPU—Kawasaki disease	0.0111	0.0297	CbGpPWpGaD
Vitamin E—GSTP1—gall bladder—Kawasaki disease	0.0107	0.0171	CbGeAlD
Vitamin E—GSTM3—heart—Kawasaki disease	0.0105	0.0168	CbGeAlD
Vitamin E—PPP2CB—Mitotic Prometaphase—CENPU—Kawasaki disease	0.0104	0.0279	CbGpPWpGaD
Vitamin E—PPP2CA—Resolution of Sister Chromatid Cohesion—CENPU—Kawasaki disease	0.0104	0.0278	CbGpPWpGaD
Vitamin E—GSTO1—heart—Kawasaki disease	0.0098	0.0157	CbGeAlD
Vitamin E—PPP2CA—Mitotic Prometaphase—CENPU—Kawasaki disease	0.00978	0.0261	CbGpPWpGaD
Vitamin E—GSTO1—skin of body—Kawasaki disease	0.0096	0.0153	CbGeAlD
Vitamin E—PRKCB—Thromboxane A2 receptor signaling—BLK—Kawasaki disease	0.00918	0.0246	CbGpPWpGaD
Vitamin E—NQO1—neck—Kawasaki disease	0.00909	0.0145	CbGeAlD
Vitamin E—SOD1—heart—Kawasaki disease	0.00901	0.0144	CbGeAlD
Vitamin E—PRKCA—heart—Kawasaki disease	0.00873	0.0139	CbGeAlD
Vitamin E—PRKCA—skin of body—Kawasaki disease	0.00855	0.0137	CbGeAlD
Vitamin E—GSTA2—heart—Kawasaki disease	0.00836	0.0134	CbGeAlD
Vitamin E—HMOX1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—Kawasaki disease	0.00825	0.0221	CbGpPWpGaD
Vitamin E—GSTP1—cardiac ventricle—Kawasaki disease	0.00818	0.0131	CbGeAlD
Vitamin E—GSTP1—neck—Kawasaki disease	0.00812	0.013	CbGeAlD
Vitamin E—GSTP1—myocardium—Kawasaki disease	0.00769	0.0123	CbGeAlD
Vitamin E—PPP2CB—Separation of Sister Chromatids—CENPU—Kawasaki disease	0.00762	0.0204	CbGpPWpGaD
Vitamin E—PPP2CB—Mitotic Anaphase—CENPU—Kawasaki disease	0.00723	0.0193	CbGpPWpGaD
Vitamin E—PPP2CB—Mitotic Metaphase and Anaphase—CENPU—Kawasaki disease	0.00719	0.0192	CbGpPWpGaD
Vitamin E—PPP2CA—Separation of Sister Chromatids—CENPU—Kawasaki disease	0.00714	0.0191	CbGpPWpGaD
Vitamin E—PPP2CA—Mitotic Anaphase—CENPU—Kawasaki disease	0.00677	0.0181	CbGpPWpGaD
Vitamin E—PPP2CA—Mitotic Metaphase and Anaphase—CENPU—Kawasaki disease	0.00674	0.018	CbGpPWpGaD
Vitamin E—ALOX5—heart—Kawasaki disease	0.00653	0.0104	CbGeAlD
Vitamin E—NQO1—heart—Kawasaki disease	0.00601	0.0096	CbGeAlD
Vitamin E—PRKCB—B Cell Receptor Signaling Pathway—BLK—Kawasaki disease	0.00592	0.0158	CbGpPWpGaD
Vitamin E—NQO1—skin of body—Kawasaki disease	0.00588	0.0094	CbGeAlD
Vitamin E—GSTP1—heart—Kawasaki disease	0.00537	0.00858	CbGeAlD
Vitamin E—SOD1—Vitamin B12 Metabolism—CRP—Kawasaki disease	0.00537	0.0143	CbGpPWpGaD
Vitamin E—GSTP1—skin of body—Kawasaki disease	0.00526	0.0084	CbGeAlD
Vitamin E—PRKCB—M Phase—CENPU—Kawasaki disease	0.00486	0.013	CbGpPWpGaD
Vitamin E—PPP2CB—M Phase—CENPU—Kawasaki disease	0.00467	0.0125	CbGpPWpGaD
Vitamin E—HMOX1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.00466	0.0125	CbGpPWpGaD
Vitamin E—PRKCA—Thromboxane A2 receptor signaling—BLK—Kawasaki disease	0.00466	0.0125	CbGpPWpGaD
Vitamin E—PRKCB—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.00446	0.0119	CbGpPWpGaD
Vitamin E—PRKCB—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.0044	0.0118	CbGpPWpGaD
Vitamin E—PPP2CA—M Phase—CENPU—Kawasaki disease	0.00438	0.0117	CbGpPWpGaD
Vitamin E—SOD1—Folate Metabolism—CRP—Kawasaki disease	0.00437	0.0117	CbGpPWpGaD
Vitamin E—PPP2CA—PDGFR-beta signaling pathway—BLK—Kawasaki disease	0.00435	0.0116	CbGpPWpGaD
Vitamin E—GCLC—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.00428	0.0115	CbGpPWpGaD
Vitamin E—PPP2CB—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.00428	0.0115	CbGpPWpGaD
Vitamin E—HMOX1—Metabolism—ITPKC—Kawasaki disease	0.00407	0.0109	CbGpPWpGaD
Vitamin E—PPP2CA—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.00401	0.0107	CbGpPWpGaD
Vitamin E—PRKCB—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.00387	0.0104	CbGpPWpGaD
Vitamin E—GSTM3—Metabolism—ITPKC—Kawasaki disease	0.0037	0.00988	CbGpPWpGaD
Vitamin E—SOD1—Selenium Micronutrient Network—CRP—Kawasaki disease	0.00347	0.00927	CbGpPWpGaD
Vitamin E—PRKCB—B Cell Activation—BLK—Kawasaki disease	0.00338	0.00905	CbGpPWpGaD
Vitamin E—GSTO1—Metabolism—ITPKC—Kawasaki disease	0.00334	0.00894	CbGpPWpGaD
Vitamin E—PRKCB—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.00333	0.00892	CbGpPWpGaD
Vitamin E—PPP2CB—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.0032	0.00856	CbGpPWpGaD
Vitamin E—PPP2CA—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.003	0.00802	CbGpPWpGaD
Vitamin E—PRKCB—Cell Cycle—CENPU—Kawasaki disease	0.00298	0.00797	CbGpPWpGaD
Vitamin E—PRKCB—TCR signaling in naïve CD4+ T cells—CD4—Kawasaki disease	0.00291	0.00779	CbGpPWpGaD
Vitamin E—PPP2CB—Cell Cycle—CENPU—Kawasaki disease	0.00286	0.00766	CbGpPWpGaD
Vitamin E—ALOX5—Selenium Micronutrient Network—CRP—Kawasaki disease	0.00286	0.00764	CbGpPWpGaD
Vitamin E—GCLC—Metabolism—ITPKC—Kawasaki disease	0.0028	0.00749	CbGpPWpGaD
Vitamin E—PPP2CB—Costimulation by the CD28 family—CD4—Kawasaki disease	0.00273	0.00731	CbGpPWpGaD
Vitamin E—PPP2CA—Cell Cycle—CENPU—Kawasaki disease	0.00268	0.00717	CbGpPWpGaD
Vitamin E—PRKCA—Spinal Cord Injury—FCGR2A—Kawasaki disease	0.00265	0.00708	CbGpPWpGaD
Vitamin E—NQO1—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.00262	0.007	CbGpPWpGaD
Vitamin E—SOD1—AGE/RAGE pathway—MMP9—Kawasaki disease	0.00257	0.00687	CbGpPWpGaD
Vitamin E—PPP2CA—Costimulation by the CD28 family—CD4—Kawasaki disease	0.00256	0.00684	CbGpPWpGaD
Vitamin E—PRKCB—AGE/RAGE pathway—MMP9—Kawasaki disease	0.00254	0.00678	CbGpPWpGaD
Vitamin E—PRKCA—Extracellular matrix organization—ITGAE—Kawasaki disease	0.00254	0.00678	CbGpPWpGaD
Vitamin E—PRKCA—M Phase—CENPU—Kawasaki disease	0.00247	0.0066	CbGpPWpGaD
Vitamin E—PRKCA—PDGFR-beta signaling pathway—BLK—Kawasaki disease	0.00245	0.00655	CbGpPWpGaD
Vitamin E—PRKCB—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.00231	0.00617	CbGpPWpGaD
Vitamin E—PRKCA—Syndecan-4-mediated signaling events—MMP9—Kawasaki disease	0.0023	0.00614	CbGpPWpGaD
Vitamin E—PRKCA—Mitotic M-M/G1 phases—CENPU—Kawasaki disease	0.00226	0.00605	CbGpPWpGaD
Vitamin E—PRKCA—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.00223	0.00597	CbGpPWpGaD
Vitamin E—PRKCB—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.00222	0.00595	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—ITPKC—Kawasaki disease	0.00212	0.00568	CbGpPWpGaD
Vitamin E—SOD1—Platelet degranulation—VEGFA—Kawasaki disease	0.00198	0.00529	CbGpPWpGaD
Vitamin E—PRKCA—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.00196	0.00525	CbGpPWpGaD
Vitamin E—DGKA—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.00192	0.00514	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—ITPKC—Kawasaki disease	0.00191	0.00511	CbGpPWpGaD
Vitamin E—SOD1—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	0.00188	0.00504	CbGpPWpGaD
Vitamin E—PRKCB—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	0.00186	0.00498	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—ITPKC—Kawasaki disease	0.00179	0.00478	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—ITPKC—Kawasaki disease	0.00176	0.0047	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—ITPKC—Kawasaki disease	0.00171	0.00458	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle, Mitotic—CENPU—Kawasaki disease	0.00169	0.00452	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—ITPKC—Kawasaki disease	0.00166	0.00443	CbGpPWpGaD
Vitamin E—PRKCB—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.00155	0.00414	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle—CENPU—Kawasaki disease	0.00151	0.00404	CbGpPWpGaD
Vitamin E—PRKCA—TCR signaling in naïve CD4+ T cells—CD4—Kawasaki disease	0.00148	0.00395	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by VEGF—VEGFA—Kawasaki disease	0.00146	0.00391	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—FCGR2A—Kawasaki disease	0.00141	0.00376	CbGpPWpGaD
Vitamin E—PRKCB—Adaptive Immune System—BLK—Kawasaki disease	0.00136	0.00365	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—FCGR2A—Kawasaki disease	0.00132	0.00352	CbGpPWpGaD
Vitamin E—PPP2CB—Adaptive Immune System—BLK—Kawasaki disease	0.00131	0.00351	CbGpPWpGaD
Vitamin E—PRKCA—AGE/RAGE pathway—MMP9—Kawasaki disease	0.00129	0.00344	CbGpPWpGaD
Vitamin E—DGKA—GPCR downstream signaling—CCR5—Kawasaki disease	0.00128	0.00341	CbGpPWpGaD
Vitamin E—PPP2CA—Adaptive Immune System—BLK—Kawasaki disease	0.00123	0.00328	CbGpPWpGaD
Vitamin E—PRKCA—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.00117	0.00313	CbGpPWpGaD
Vitamin E—DGKA—Signaling by GPCR—CCR5—Kawasaki disease	0.00116	0.0031	CbGpPWpGaD
Vitamin E—PRKCB—Adaptive Immune System—CD40—Kawasaki disease	0.00113	0.00303	CbGpPWpGaD
Vitamin E—PRKCA—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.00113	0.00302	CbGpPWpGaD
Vitamin E—PPP2CB—Adaptive Immune System—CD40—Kawasaki disease	0.00109	0.00291	CbGpPWpGaD
Vitamin E—PPP2CA—Adaptive Immune System—CD40—Kawasaki disease	0.00102	0.00273	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—ITPKC—Kawasaki disease	0.00101	0.0027	CbGpPWpGaD
Vitamin E—DGKA—Hemostasis—VEGFA—Kawasaki disease	0.000991	0.00265	CbGpPWpGaD
Vitamin E—PRKCA—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	0.000944	0.00252	CbGpPWpGaD
Vitamin E—SOD1—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000877	0.00235	CbGpPWpGaD
Vitamin E—PRKCB—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000866	0.00232	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—FCGR2A—Kawasaki disease	0.000853	0.00228	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—BLK—Kawasaki disease	0.000828	0.00221	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—FCGR2A—Kawasaki disease	0.00082	0.00219	CbGpPWpGaD
Vitamin E—PRKCA—Spinal Cord Injury—MMP9—Kawasaki disease	0.000809	0.00216	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—BLK—Kawasaki disease	0.000795	0.00213	CbGpPWpGaD
Vitamin E—PRKCA—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000785	0.0021	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—FCGR2A—Kawasaki disease	0.000768	0.00205	CbGpPWpGaD
Vitamin E—SOD1—Cellular responses to stress—VEGFA—Kawasaki disease	0.000761	0.00203	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—BLK—Kawasaki disease	0.000745	0.00199	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—FCGR2A—Kawasaki disease	0.000743	0.00199	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by VEGF—VEGFA—Kawasaki disease	0.000741	0.00198	CbGpPWpGaD
Vitamin E—GSTO1—Disease—CCR5—Kawasaki disease	0.00074	0.00198	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—CRP—Kawasaki disease	0.000731	0.00195	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by SCF-KIT—MMP9—Kawasaki disease	0.000701	0.00188	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—CD40—Kawasaki disease	0.000688	0.00184	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—CRP—Kawasaki disease	0.000685	0.00183	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—CCR5—Kawasaki disease	0.000684	0.00183	CbGpPWpGaD
Vitamin E—GSTP1—Cellular responses to stress—VEGFA—Kawasaki disease	0.000664	0.00177	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—CD40—Kawasaki disease	0.000661	0.00177	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—CD40—Kawasaki disease	0.000619	0.00165	CbGpPWpGaD
Vitamin E—PRKCB—GPCR downstream signaling—CCR5—Kawasaki disease	0.000575	0.00154	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by GPCR—CCR5—Kawasaki disease	0.000522	0.0014	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling by GPCR—CCR5—Kawasaki disease	0.000501	0.00134	CbGpPWpGaD
Vitamin E—PRKCA—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	0.000494	0.00132	CbGpPWpGaD
Vitamin E—PPP2CB—Innate Immune System—CD4—Kawasaki disease	0.000494	0.00132	CbGpPWpGaD
Vitamin E—PRKCB—Adaptive Immune System—CD4—Kawasaki disease	0.000494	0.00132	CbGpPWpGaD
Vitamin E—PPP2CB—Adaptive Immune System—CD4—Kawasaki disease	0.000474	0.00127	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling by GPCR—CCR5—Kawasaki disease	0.000469	0.00126	CbGpPWpGaD
Vitamin E—GSTO1—Disease—CD4—Kawasaki disease	0.000465	0.00124	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—CD4—Kawasaki disease	0.000462	0.00124	CbGpPWpGaD
Vitamin E—SOD1—Hemostasis—VEGFA—Kawasaki disease	0.000452	0.00121	CbGpPWpGaD
Vitamin E—PRKCB—Hemostasis—VEGFA—Kawasaki disease	0.000447	0.00119	CbGpPWpGaD
Vitamin E—PPP2CA—Adaptive Immune System—CD4—Kawasaki disease	0.000444	0.00119	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—CRP—Kawasaki disease	0.000443	0.00119	CbGpPWpGaD
Vitamin E—PRKCA—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000439	0.00118	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—FCGR2A—Kawasaki disease	0.000433	0.00116	CbGpPWpGaD
Vitamin E—PPP2CB—Hemostasis—VEGFA—Kawasaki disease	0.000429	0.00115	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—CRP—Kawasaki disease	0.000426	0.00114	CbGpPWpGaD
Vitamin E—PRKCA—Extracellular matrix organization—MMP9—Kawasaki disease	0.000425	0.00114	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—CCR5—Kawasaki disease	0.000423	0.00113	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—BLK—Kawasaki disease	0.00042	0.00112	CbGpPWpGaD
Vitamin E—PPP2CA—Hemostasis—VEGFA—Kawasaki disease	0.000402	0.00107	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—CRP—Kawasaki disease	0.000399	0.00107	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—CCR5—Kawasaki disease	0.000396	0.00106	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—CRP—Kawasaki disease	0.000386	0.00103	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—MMP9—Kawasaki disease	0.000374	0.001	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—CD40—Kawasaki disease	0.000349	0.000933	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—VEGFA—Kawasaki disease	0.000336	0.000898	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—CCR5—Kawasaki disease	0.000308	0.000824	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—CD4—Kawasaki disease	0.000299	0.000801	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—CCR5—Kawasaki disease	0.000296	0.000792	CbGpPWpGaD
Vitamin E—PRKCA—GPCR downstream signaling—CCR5—Kawasaki disease	0.000292	0.00078	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—CD4—Kawasaki disease	0.000288	0.000769	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—CCR5—Kawasaki disease	0.000277	0.000742	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—CD4—Kawasaki disease	0.000269	0.00072	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—CD4—Kawasaki disease	0.000266	0.00071	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—CCR5—Kawasaki disease	0.000265	0.000708	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—CD4—Kawasaki disease	0.000261	0.000697	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—CD4—Kawasaki disease	0.000249	0.000665	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—VEGFA—Kawasaki disease	0.000227	0.000606	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—CRP—Kawasaki disease	0.000225	0.000601	CbGpPWpGaD
Vitamin E—PRKCA—Disease—CCR5—Kawasaki disease	0.000223	0.000597	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—MMP9—Kawasaki disease	0.000169	0.000451	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—MMP9—Kawasaki disease	0.000162	0.000433	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—CCR5—Kawasaki disease	0.000156	0.000418	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—CD4—Kawasaki disease	0.000152	0.000406	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—MMP9—Kawasaki disease	0.000152	0.000406	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—VEGFA—Kawasaki disease	0.000151	0.000405	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—VEGFA—Kawasaki disease	0.000145	0.000389	CbGpPWpGaD
Vitamin E—PRKCA—Disease—CD4—Kawasaki disease	0.00014	0.000375	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—VEGFA—Kawasaki disease	0.000136	0.000364	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—MMP9—Kawasaki disease	8.55e-05	0.000229	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—VEGFA—Kawasaki disease	7.68e-05	0.000205	CbGpPWpGaD
